Phase II and Phase III attrition rates 2011–2012

Arrowsmith, John, Miller, Philip·2013·Nature Reviews Drug Discovery
DOI 10.1038/nrd4090

Cited by (697)

Items 101–200 of 697

  1. Human Genetics of Obesity and Type 2 Diabetes Mellitus
    Erik Ingelsson, Mark I. McCarthy · 2018 · Circulation Genomic and Precision Medicine
  2. 3D Culture Systems for Exploring Cancer Immunology
    Allison A. Fitzgerald, Eric Li, Louis M. Weiner · 2020 · Cancers
  3. Effect of surfactant on the size and stability of PLGA nanoparticles encapsulating a protein kinase C inhibitor
    Blerina Shkodra, Christian Grune, Anja Traeger, Antje Vollrath, Stephanie Schubert, Dagmar Fischer, Ulrich S. Schubert · 2019 · International Journal of Pharmaceutics
  4. Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape
    Marjoleen Nijsen, Fan Wu, Loveleena Bansal, Erica L. Bradshaw‐Pierce, Jason R. Chan, Bianca M. Liederer, Jerome Thomas Mettetal, Patricia E. Schroeder, Edgar L. Schuck, Alice Tsai et al. · 2018 · CPT Pharmacometrics & Systems Pharmacology
  5. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
    Nobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, Gen Hiyama, Hirosumi Tamura, Mayu Ogawa, Kosuke Takagi, Kazuhito Goda, Naoyuki Okabe, Satoshi Muto et al. · 2019 · Cells
  6. An effector index to predict target genes at GWAS loci
    Vincenzo Forgetta, Lai Jiang, Nicholas A. Vulpescu, Megan S. Hogan, Siyuan Chen, John A. Morris, Stepan Grinek, Christian Benner, Dongkeun Jang, Quy Hoang et al. · 2022 · Human Genetics
  7. DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome
    Anis Féki, Youssef Hibaoui · 2018 · Brain Sciences
  8. Engineering microphysiological immune system responses on chips
    Miller, Chris P., Shin, Woojung, Ahn, Eun Hyun, Kim, Hyun Jung, Kim, Deok-Ho · 2020 · Trends in biotechnology
  9. Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
    Rajesh Kumar, Seetha Harilal, Sheeba Varghese Gupta, Jobin Jose, Della Grace Thomas Parambi, Md. Sahab Uddin, Muhammad Ajmal Shah, Bijo Mathew · 2019 · European Journal of Medicinal Chemistry
  10. Practically convenient and industrially-aligned methods for iridium-catalysed hydrogen isotope exchange processes
    Alison R. Cochrane, Christopher Idziak, William J. Kerr · 2014 · Organic & Biomolecular Chemistry
  11. Multiple grid arrangement improves ligand docking with unknown binding sites: Application to the inverse docking problem
    Tomohiro Ban, Masahito Ohue, Yutaka Akiyama · 2018 · Computational Biology and Chemistry
  12. Maximizing the impact of microphysiological systems with in vitro – in vivo translation
    Murat Cirit, Cynthia L. Stokes · 2018 · Lab on a Chip
  13. Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment
    Mira Stadler, Stefanie Walter, Angelika Walzl, Nina Kramer, Christine Unger, Martin Scherzer, Daniela Unterleuthner, Markus Hengstschläger, Georg Krupitza, Helmut Dolznig · 2015 · Seminars in Cancer Biology
  14. Mendelian randomisation applied to drug development in cardiovascular disease: a review
    Lauren E. Mokry, Omar S. Ahmad, Vincenzo Forgetta, George Thanassoulis, John Brent Richards · 2014 · Journal of Medical Genetics
  15. A standardised framework to identify optimal animal models for efficacy assessment in drug development
    Guilherme S. Ferreira, Désirée H. Veening-Griffioen, Wouter Boon, Ellen H.M. Moors, Christine C. Gispen‐de Wied, Huub Schellekens, Peter J.K. van Meer · 2019 · PLoS ONE
  16. Genetic Insights for Drug Development in NAFLD
    Mohammed Eslam, Jacob George · 2019 · Trends in Pharmacological Sciences
  17. Structural basis of IL-23 antagonism by an Alphabody protein scaffold
    Johan Desmet, Kenneth Verstraete, Yehudi Bloch, Eric Lorent, Yurong Wen, Bart V. Devreese, Karen Vandenbroucke, Stefan Loverix, Thore Hettmann, Sabrina Deroo et al. · 2014 · Nature Communications
  18. Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice
    Alexander Egger, Sarah Theiner, Christoph Kornauth · 2014 · Metallomics
  19. Biological Relevance and Therapeutic Potential of the Hypusine Modification System
    Nora Pällmann, Melanie Braig, Henning Sievert, Michael Preukschas, Irm Hermans‐Borgmeyer, Michaela Schweizer, Claus‐Henning Nagel, Melanie Neumann, Peter Johannes Wild, Eugenia Haralambieva et al. · 2015 · Journal of Biological Chemistry
  20. Refining animal research: The Animal Study Registry
    Bert, Bettina, Heinl, Céline, Chmielewska, Justyna, Schwarz, Franziska, Grune, Barbara, Hensel, Andreas, Greiner, Matthias, Schönfelder, Gilbert · 2019 · PLOS Biology
  21. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model
    Genevieve Conant, Benjamin Fook Lun Lai, Rick Xing Ze Lu, Anastasia Korolj, Erika Yan Wang, Milica Radisic · 2017 · Stem Cell Reviews and Reports
  22. Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes
    Misawa Niki Ishii, Koji Yamamoto, Masanobu Shoji, Asano Asami, Yuji Kawamata · 2017 · Toxicology
  23. Early Implementation of QbD in Biopharmaceutical Development: A Practical Example
    Jesús Zurdo, Andreas Arnell, Olga Obrezanova, Noel Smith, Ramón Gómez de la Cuesta, Thomas R. A. Gallagher, Rebecca Michael, Yvette Stallwood, Caroline Ekblad, Lars Abrahmsén et al. · 2015 · BioMed Research International
  24. Livestock Models in Translational Medicine
    James A. Roth, Christopher Keith Tuggle · 2015 · ILAR Journal
  25. Drug Design Workshop: A Web-Based Educational Tool To Introduce Computer-Aided Drug Design to the General Public
    Antoine Daina, Marie-Claude Blatter, Vivienne Baillie Gerritsen, Patricia M. Palagi, Diana Marek, Ioannis Xénarios, Torsten F. Schwede, Olivier Alain Michielin, Vincent Zoete · 2017 · Journal of Chemical Education
  26. Deep learning in structural bioinformatics: current applications and future perspectives
    Niranjan Kumar, Rakesh Kumar Srivastava · 2024 · Briefings in Bioinformatics
  27. Discontinued in 2013: oncology drugs
    Robert Williams · 2014 · Expert Opinion on Investigational Drugs
  28. Large animal models of rare genetic disorders: sheep as phenotypically relevant models of human genetic disease
    Ashish R. Pinnapureddy, Cherie Stayner, John Colin McEwan, Olivia Baddeley, John Forman, Michael Roger Eccles · 2015 · Orphanet Journal of Rare Diseases
  29. Deep Learning for Drug Discovery and Cancer Research: Automated Analysis of Vascularization Images
    Gregor Urban, Kevin Bache, Duc T. T. Phan, Agua Sobrino, Alexander Shmakov, Stephanie J. Hachey, Christopher C.W. Hughes, Pierre Baldi · 2018 · IEEE Transactions on Computational Biology and Bioinformatics
  30. Embedding of Precision-Cut Lung Slices in Engineered Hydrogel Biomaterials Supports Extended Ex Vivo Culture
    Kolene E. Bailey, Christopher J. Pino, Mallory L. Lennon, Anne C. Lyons, Jeffrey G. Jacot, Steven R. Lammers, Mélanie Königshoff, Chelsea M. Magin · 2019 · American Journal of Respiratory Cell and Molecular Biology
  31. Automated fabrication of photopatterned gelatin hydrogels for organ-on-chips applications
    Janna C. Nawroth, Lisa L Scudder, Ryan T. Halvorson, Jason S. Tresback, John P. Ferrier, Sean P. Sheehy, Alex Cho, Suraj Kannan, Ilona Sunyovszki, Josue A. Goss et al. · 2018 · Biofabrication
  32. The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
    Mark F. Coughlin, Roger Dale Kamm · 2020 · Advanced Healthcare Materials
  33. The emerging role of in vitro electrophysiological methods in CNS safety pharmacology
    Michael V. Accardi, Michael K. Pugsley, Roy Ph. Forster, Éric Troncy, Hai Huang, Simon Authier · 2016 · Journal of Pharmacological and Toxicological Methods
  34. Decision‐making in early clinical drug development
    Paul Frewer, Pat Mitchell, Claire L Watkins, James Matcham · 2016 · Pharmaceutical Statistics
  35. Developing nociceptor-selective treatments for acute and chronic pain
    Selwyn S. Jayakar, Jaehoon Shim, Sooyeon Jo, Bruce P. Bean, Ilyas Singeç, Clifford J. Woolf · 2021 · Science Translational Medicine
  36. Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract
    Tuula Heinonen, Wilhelm Gaus · 2014 · Toxicology
  37. Human liver organoids: From generation to applications
    Afonso, Marta B., Marques, Vanda, van Mil, Saskia W.C., Rodrigues, Cecilia M.P. · 2024 · Hepatology
  38. Towards a sustainable system of drug development
    Ellen H.M. Moors, Adam F. Cohen, Huub Schellekens · 2014 · Drug Discovery Today
  39. Key indicators of phase transition for clinical trials through machine learning
    Felipe Feijoo, Michele Palopoli, Jen Bernstein, Sauleh Siddiqui, Tenley E. Albright · 2020 · Drug Discovery Today
  40. Stem Cell-Derived Systems in Toxicology Assessment
    Laura Suter‐Dick, Paula M. Alves, Bas J. Blaauboer, Klaus-Dieter Bremm, Catarina Brito, Sandra Coecke, Burkhard Flick, Paul Fowler, Jürgen Hescheler, Magnus Ingelman‐Sundberg et al. · 2015 · Stem Cells and Development
  41. Matrix Factorization-based Technique for Drug Repurposing Predictions
    Gaia Ceddia, Pietro Pinoli, Stefano Ceri, Marco Masseroli · 2020 · IEEE Journal of Biomedical and Health Informatics
  42. Recent Progress in European Advanced Therapy Medicinal Products and Beyond
    Tracy T. L. Yu, Pravesh Gupta, Vincent Ronfard, Alain A. Vertès, Yves Bayon · 2018 · Frontiers in Bioengineering and Biotechnology
  43. Applicability of hiPSC-Derived Neuronal Cocultures and Rodent Primary Cortical Cultures for In Vitro Seizure Liability Assessment
    Anke M. Tukker, Fiona M.J. Wijnolts, Aart de Groot, Remco H.S. Westerink · 2020 · Toxicological Sciences
  44. Repurposing Drugs to Target the Diabetes Epidemic
    Nigel A. Turner, Xiao‐Yi Zeng, Brenna Osborne, Suzanne Rogers, Ji-Ming Ye · 2016 · Trends in Pharmacological Sciences
  45. Valley of death: A proposal to build a “translational bridge” for the next generation
    Nao J. Gamo, Michelle Rosgaard Birknow, Danielle Sullivan, Mari Kondo, Yasue Horiuchi, Takeshi Sakurai, Barbara Stauch Slusher, Akira Sawa · 2016 · Neuroscience Research
  46. R&D efficiency of leading pharmaceutical companies – A 20-year analysis
    Alexander Schuhmacher, Lucas Wilisch, Michael Kuss, Andreas Kandelbauer, Markus Hinder, Oliver Gassmann · 2021 · Drug Discovery Today
  47. Biohybrid 3D Printing of a Tissue‐Sensor Platform for Wireless, Real‐Time, and Continuous Monitoring of Drug‐Induced Cardiotoxicity
    Uijung Yong, Donghwan Kim, Hojoong Kim, Dong Gyu Hwang, Sungkeon Cho, Hyoryung Nam, Sejin Kim, Tae Yeong Kim, Unyong Jeong, Keehoon Kim et al. · 2022 · Advanced Materials
  48. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi‐MPS Integration
    Jiajie Yu, NA Cilfone, Emma M. Large, Ujjal Sarkar, John S. Wishnok, Steven R. Tannenbaum, DJ Hughes, Douglas A. Lauffenburger, Linda Gay Griffith, CL Stokes et al. · 2015 · CPT Pharmacometrics & Systems Pharmacology
  49. Large-Scale Predictive Drug Safety: From Structural Alerts to Biological Mechanisms
    Ricard García-Serna, David Vidal, Nikita Remez, Jordi Mestres · 2015 · Chemical Research in Toxicology
  50. The NIH microphysiological systems program: developing in vitro tools for safety and efficacy in drug development
    Danilo A. Tagle · 2019 · Current Opinion in Pharmacology
  51. The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development
    Marit Keuper-Navis, Markus Walles, Birk Poller, Adam Myszczyszyn, Thomas K. van der Made, Joanne M. Donkers, Hossein Eslami Amirabadi, Martijn J. G. Wilmer, Saskia Aan, Bart Spee et al. · 2023 · Pharmacological Research
  52. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
    Farid Abd-Elreheim Badria · 2020 · IntechOpen eBooks
  53. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues
    Hirosumi Tamura, Arisa Higa, Hirotaka Hoshi, Gen Hiyama, Nobuhiko Takahashi, Masae Ryufuku, Gaku Morisawa, Yuka Yanagisawa, Emi Ito, Junichi Imai et al. · 2018 · Oncology Reports
  54. Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms
    Chris S. Pridgeon, Constanze Schlott, Min Wei Wong, Minne B. Heringa, Tobias Heckel, Joe Leedale, Laurence Launay, Vitalina Gryshkova, Stefan Alexander Przyborski, Rachel N. Bearon et al. · 2018 · Archives of Toxicology
  55. Applicability of tumor spheroids forin vitrochemosensitivity assays
    Gerhard Hamilton, Barbara Rath · 2018 · Expert Opinion on Drug Metabolism & Toxicology
  56. In silico assessment of adverse drug reactions and associated mechanisms
    Ivanov, Sergey M., Lagunin, Alexey A., Poroikov, Vladimir V. · 2016 · Drug Discovery Today
  57. Genome annotation for clinical genomic diagnostics: strengths and weaknesses
    Charles A. Steward, Alasdair P. J. Parker, Berge A. Minassian, Sanjay M. Sisodiya, Adam Frankish, Jennifer Harrow · 2017 · Genome Medicine
  58. Genome‐wide and Phenome‐wide Approaches to Understand Variable Drug Actions in Electronic Health Records
    Jamie R. Robinson, Joshua C. Denny, Dan M. Roden, Sara L. Van Driest · 2017 · Clinical and Translational Science
  59. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development
    Passley Hargrove-Grimes, Lucie A. Low, Danilo A. Tagle · 2021 · Cells Tissues Organs
  60. Mimicking the Kidney: A Key Role in Organ-on-Chip Development
    Roberto Paoli, Josep Samitier · 2016 · Micromachines
  61. Quantitative systems pharmacology: a promising approach for translational pharmacology
    Kapil G. Gadkar, Daniel C. Kirouac, Neil John Parrott, Saroja Ramanujan · 2016 · Drug Discovery Today Technologies
  62. Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents
    Leigh C. Walker, Alice E. Berizzi, Nicola A. Chen, Patricia Rueda, Victoria M. Perreau, Katherine Huckstep, Jirawoot Srisontiyakul, Piyarat Govitrapong, Xiaojian Jia, Craig W. Lindsley et al. · 2020 · Biological Psychiatry
  63. CETSA: A Target Engagement Assay with Potential to Transform Drug Discovery
    Annika Jenmalm Jensen, Daniel Martinez Molina, Thomas Lundbäck · 2015 · Future Medicinal Chemistry
  64. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies
    Samya Chakravorty, Madhuri Hegde · 2017 · Annual Review of Genomics and Human Genetics
  65. Scaling machine learning for target prediction in drug discovery using Apache Spark
    Dries Harnie, Mathijs Saey, Alexander E. Vapirev, Jörg K. Wegner, Andrey Gedich, Marvin N. Steijaert, Hugo Ceulemans, Roel Wuyts B, Wolfgang De Meuter · 2016 · Future Generation Computer Systems
  66. Drug repurposing for immune modulation in acute ischemic stroke
    Diana Amantea, Giacinto Bagetta · 2015 · Current Opinion in Pharmacology
  67. Drug Repurposing for the Development of Novel Analgesics
    Marco Sisignano, Michael John Parnham, Gerd Geißlinger · 2015 · Trends in Pharmacological Sciences
  68. Clinical protein science in translational medicine targeting malignant melanoma
    Gil, Jeovanis, Betancourt, Lazaro Hiram, Pla, Indira, Sanchez, Aniel, Appelqvist, Roger, Miliotis, Tasso, Kuras, Magdalena, Oskolas, Henriette, Kim, Yonghyo, Horvath, Zsolt et al. · 2019 · Cell Biology and Toxicology
  69. Glioblastoma modeling with 3D organoids: progress and challenges
    Wang, Xin, Sun, Yusha, Zhang, Daniel Y, Ming, Guo-li, Song, Hongjun · 2023 · Oxford Open Neuroscience
  70. Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success
    Haruhiko Sugino, Akihito Watanabe, Naoki Amada, Miho Yamamoto, Yuta Ohgi, Dusan Kostic, Raymond Sanchez · 2015 · Clinical Therapeutics
  71. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors
    Chester E. Chamberlain, Michael S. German, Katherine Y. Yang, Jason Wang, Henry F. VanBrocklin, Melanie Regan, Kevan M. Shokat, Gregory S. Ducker, Grace Kim, Byron C. Hann et al. · 2018 · Molecular Cancer Therapeutics
  72. Preclinical validation of therapeutic targets predicted by tensor factorization on heterogeneous graphs
    Saee Paliwal, Alex de Giorgio, Daniel Neil, Jean-Baptiste Michel, Alix M.B. Lacoste · 2020 · Scientific Reports
  73. Recent progress of iPSC technology in cardiac diseases
    Shunsuke Funakoshi, Yoshinori Yoshida · 2021 · Archives of Toxicology
  74. Mouse Models of Tumor Immunotherapy
    Shin Foong Ngiow, Sherene Loi, David Morgan Thomas, Mark John Smyth · 2016 · Advances in immunology
  75. Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles
    Ruili Huang, Menghang Xia, Srilatha Sakamuru, Jinghua Zhao, Caitlin Lynch, Tongan Zhao, Hu Zhu, Christopher P. Austin, Anton M. Simeonov · 2018 · Scientific Reports
  76. Differences in the Central Energy Metabolism of Cancer Cells between Conventional 2D and Novel 3D Culture Systems
    Ryo Ikari, Ken‐ichi Mukaisho, Susumu Kageyama, Masayuki Nagasawa, Shigehisa Kubota, Takahisa Nakayama, Shoko Murakami, Naoko Taniura, Hiroyuki Tanaka, Ryoji Kushima et al. · 2021 · International Journal of Molecular Sciences
  77. Recent Advances in Cell Sheet Engineering: From Fabrication to Clinical Translation
    Parichut Thummarati, Wanida Laiwattanapaisal, Rikiya Nitta, Megumi Fukuda, Artchaya Hassametto, Masahiro Kino‐oka · 2023 · Bioengineering
  78. High Accuracy in Silico Sulfotransferase Models
    Ian Thomas Cook, Ting Wang, Charles Napoleon Falany, Thomas S. Leyh · 2013 · Journal of Biological Chemistry
  79. Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson’s disease
    Caroline J. Zeiss, Heather Gwynn Allore, Amanda P. Beck · 2017 · PLoS ONE
  80. The potential of multi-organ-on-chip models for assessment of drug disposition as alternative to animal testing
    Damiën van Berlo, Evita van de Steeg, Hossein Eslami Amirabadi, Rosalinde Masereeuw · 2021 · Current Opinion in Toxicology
  81. Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
    McArthur, Robert A. · 2017 · Neuroscience & Biobehavioral Reviews
  82. Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome
    David G. J. Cucchi, Richard W.J. Groen, Jeroen J. W. M. Janssen, Jacqueline J Cloos · 2020 · Drug Resistance Updates
  83. Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View
    Justus Körfer, Florian Lordick, Ulrich Thorsten Hacker · 2021 · Cancers
  84. Livestock Models for Exploiting the Promise of Pluripotent Stem Cells
    R. M. Roberts, Ye Yuan, Nicholas J. Genovese · 2015 · ILAR Journal
  85. Synthesis and in vivo anticancer evaluation of poly(organo)phosphazene-based metallodrug conjugates
    Carmen M. Hackl, Beatrix Alte, Matthias H. M. Klose, Helena Henke, Maria S. Legina, Michael A. Jakupec, Walter Berger, Bernhard K. Keppler, Oliver Brüggemann, Ian Teasdale et al. · 2017 · Dalton Transactions
  86. Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study
    Lauren E. Mokry, Sirui Zhou, Cong Guo, Robert A. Scott, Luke R. Devey, Claudia Langenberg, Nicholas J. Wareham, Dawn M. Waterworth, Lon R. Cardon, Philippe Sanséau et al. · 2019 · Scientific Reports
  87. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation
    Xiaoli Tang, Zengwu Wang, Shengshou Hu, Bingying Zhou · 2022 · Pharmaceutics
  88. Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish
    Zehra Yıldırım, Kyle Swanson, Xuekun Wu, James Zou, Joseph C. Wu · 2024 · The Annual Review of Pharmacology and Toxicology
  89. Synthetic Lethal Vulnerabilities of Cancer
    Ferran Fece de la Cruz, Bianca V. Gapp, Sebastian M. B. Nijman · 2014 · The Annual Review of Pharmacology and Toxicology
  90. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph
    Nicholas A. Meanwell · 2016 · Journal of Medicinal Chemistry
  91. The Benefits of In Silico Modeling to Identify Possible Small-Molecule Drugs and Their Off-Target Interactions
    Mire Zloh, Stewart Brian Kirton · 2018 · Future Medicinal Chemistry
  92. Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine
    Zhan Tong, Yuan Zhou, Juan Wang · 2019 · Scientific Reports
  93. Models of Idiosyncratic Drug-Induced Liver Injury
    Tsuyoshi Yokoi, Shingo Oda · 2020 · The Annual Review of Pharmacology and Toxicology
  94. A transcriptome comparison of time-matched developing human, mouse and rat neural progenitor cells reveals human uniqueness
    Stefan Masjosthusmann, Daniel Becker, Barbara Petzuch, Jördis Klose, Clara Siebert, René Deenen, Marta Barenys, Jenny Baumann, Katharina Dach, Julia Tigges et al. · 2018 · Toxicology and Applied Pharmacology
  95. Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs
    Raphael T. Gerraty, Allison C. Provost, Lin Li, Erin A. Wagner, Magali Haas, Lee Lancashire · 2023 · Frontiers in Aging Neuroscience
  96. Engineering brain-on-a-chip platforms
    Bram Servais, Negar Mahmoudi, Vini Gautam, Wei Tong, Michael R. Ibbotson, David R. Nisbet, David J. Collins · 2024 · Nature Reviews Bioengineering
  97. Bone Marrow Microenvironment-On-Chip for Culture of Functional Hematopoietic Stem Cells
    Azmeer Sharipol, Maggie L. Lesch, Celia A. Soto, Benjamin J. Frisch · 2022 · Frontiers in Bioengineering and Biotechnology
  98. Clinical Trial in a Dish
    Chi Keung Lam, Joseph C. Wu · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  99. Designing small molecules for therapeutic success: A contemporary perspective
    Tristan S. Maurer, Martin P. Edwards, David Hepworth, Patrick R. Verhoest, Charlotte M. N. Allerton · 2021 · Drug Discovery Today
  100. Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
    Jian Teng, Seyedali Hejazi, Lotte Hiddingh, Lítia Alves de Carvalho, Mark C. de Gooijer, Hiroaki Wakimoto, Marco Barazas, Marie Tannous, Andrew S Chi, David P. Noske et al. · 2017 · Neuro-Oncology